SAKAR logo

Sakar Healthcare Limited

SAKAR·NSE·
964.35 +101.00 (+11.70%)
Market Cap1975.79 Cr
PE Ratio70.39
Volume11,58,860
Day High - Low999.00 - 864.00
52W High-Low999.00 - 321.05
DocStoX Score
5.9/10
Fair
Fair Value
Sign in to see
ROE
6.13%
Weak
P/E
70.39x
Expensive
Debt / Equity
0.22
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day864.00
999.00
52W321.05
999.00
DocStoX take

Supported by growth (9.3) and risk (7.7), but held back by valuation (0.0). Growth looks strong at 9.3, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.9
/10
Fair
Quality
Solid
ROE 6.1%
Valuation
Expensive
P/E 70.4×
Growth
Strong
Revenue +21.5% 5Y CAGR
Risk
Low risk
D/E 0.22
Momentum
Strong
95% of 52-week range

At a glance

Market Cap
₹1,976 Cr
52W High / Low
₹999 / ₹321
Dividend Yield
0.00%
Promoter Holding
52.52%
EPS (TTM)
₹13.70
Book Value
₹145.82

Key highlights

  • Low leverage — D/E 0.22
  • Profitable in all of the last 5 years
  • Profit compounding 23% a year
  • Valuation is weak (0.0/10)
  • Expensive at 70× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

SAKAR HEALTHCARE LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.